0 Avaliações

ID

5056

Descrição

ODM derived from http://clinicaltrials.gov/show/NCT00968708

Link

http://clinicaltrials.gov/show/NCT00968708

Palavras-chave

  1. 07/12/2013 07/12/2013 - Martin Dugas
  2. 17/04/2014 17/04/2014 - Julian Varghese
Transferido a

17 de abril de 2014

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Eligibility NCT00968708 Diabetes Mellitus, Type 2

    1. StudyEvent: Eligibility
      1. Eligibility
    Einschlusskriterien
    Descrição

    Einschlusskriterien

    Alias
    UMLS CUI 2011AA
    CL425202
    Alter mindestens 18 Jahre
    Descrição

    age at least 18 Years

    Tipo de dados

    boolean

    Alias
    UMLS CUI 2011AA
    C0001779
    SNOMED CT 2011_0131
    397669002
    Diagnosis of type 2 diabetes mellitus
    Descrição

    Diagnosis of type 2 diabetes mellitus

    Tipo de dados

    boolean

    Alias
    UMLS CUI 2011AA
    C0011860
    ICD-10-CM Version 2010
    E08-E13
    Subject is receiving monotherapy or combination antidiabetic therapy with a glycosylated hemoglobin level between 6.5% and 11.0%, inclusive, at Screening (between 7.0 and 11.0%, inclusive, if the subject's antidiabetic regimen includes insulin)
    Descrição

    Subject is receiving monotherapy or combination antidiabetic therapy with a glycosylated hemoglobin level between 6.5% and 11.0%, inclusive, at Screening (between 7.0 and 11.0%, inclusive, if the subject's antidiabetic regimen includes insulin)

    Tipo de dados

    boolean

    Alias
    UMLS CUI 2011AA
    C0205171
    SNOMED CT 2011_0131
    50607009
    UMLS CUI 2011AA
    C0039798
    UMLS CUI 2011AA
    C0556895
    SNOMED CT 2011_0131
    229554006
    UMLS CUI 2011AA
    C0521124
    SNOMED CT 2011_0131
    65897001
    UMLS CUI 2011AA
    C0011849
    SNOMED CT 2011_0131
    191044006
    UMLS CUI 2011AA
    C1319284
    SNOMED CT 2011_0131
    408254005
    UMLS CUI 2011AA
    C1409616
    Diagnosis of acute coronary syndrome within 15 to 90 days prior to randomization
    Descrição

    Diagnosis of acute coronary syndrome within 15 to 90 days prior to randomization

    Tipo de dados

    boolean

    Alias
    UMLS CUI 2011AA
    C0011900
    SNOMED CT 2011_0131
    439401001
    LOINC Version 232
    MTHU008876
    UMLS CUI 2011AA
    C0948089
    SNOMED CT 2011_0131
    394659003
    MedDRA 14.1
    10051592
    CTCAE 1105E
    E10066
    UMLS CUI 2011AA
    C0332152
    SNOMED CT 2011_0131
    288556008
    UMLS CUI 2011AA
    C0034656
    Ausschlusskriterien
    Descrição

    Ausschlusskriterien

    Alias
    UMLS CUI 2011AA
    CL425201
    Signs of type 1 diabetes mellitus
    Descrição

    Signs of type 1 diabetes mellitus

    Tipo de dados

    boolean

    Alias
    UMLS CUI 2011AA
    C0011854
    Currently receiving a glucagon-like peptide-1 analogue for glycemic control of type 2 diabetes mellitus at Screening
    Descrição

    Currently receiving a glucagon-like peptide-1 analogue for glycemic control of type 2 diabetes mellitus at Screening

    Tipo de dados

    boolean

    Alias
    UMLS CUI 2011AA
    C1514756
    UMLS CUI 2011AA
    C0061355
    SNOMED CT 2011_0131
    43004008
    UMLS CUI 2011AA
    C0243071
    UMLS CUI 2011AA
    C0005802
    UMLS CUI 2011AA
    C2587213
    SNOMED CT 2011_0131
    31509003
    UMLS CUI 2011AA
    C0011860
    SNOMED CT 2011_0131
    44054006
    MedDRA 14.1
    10012613
    ICD-10-CM Version 2010
    E08-E13
    UMLS CUI 2011AA
    C1409616
    Received a dipeptidyl peptidase-4 inhibitor for either more than 14 days total or within the 3 months prior to Screening
    Descrição

    Received a dipeptidyl peptidase-4 inhibitor for either more than 14 days total or within the 3 months prior to Screening

    Tipo de dados

    boolean

    Alias
    UMLS CUI 2011AA
    C1514756
    UMLS CUI 2011AA
    C1827106
    SNOMED CT 2011_0131
    423837000

    Similar models

    Eligibility

    1. StudyEvent: Eligibility
      1. Eligibility
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    Einschlusskriterien
    CL425202 (UMLS CUI 2011AA)
    age at least 18 Years
    Item
    Alter mindestens 18 Jahre
    boolean
    C0001779 (UMLS CUI 2011AA)
    397669002 (SNOMED CT 2011_0131)
    Diagnosis of type 2 diabetes mellitus
    Item
    Diagnosis of type 2 diabetes mellitus
    boolean
    C0011860 (UMLS CUI 2011AA)
    E08-E13 (ICD-10-CM Version 2010)
    Subject is receiving monotherapy or combination antidiabetic therapy with a glycosylated hemoglobin level between 6.5% and 11.0%, inclusive, at Screening (between 7.0 and 11.0%, inclusive, if the subject's antidiabetic regimen includes insulin)
    Item
    Subject is receiving monotherapy or combination antidiabetic therapy with a glycosylated hemoglobin level between 6.5% and 11.0%, inclusive, at Screening (between 7.0 and 11.0%, inclusive, if the subject's antidiabetic regimen includes insulin)
    boolean
    C0205171 (UMLS CUI 2011AA)
    50607009 (SNOMED CT 2011_0131)
    C0039798 (UMLS CUI 2011AA)
    C0556895 (UMLS CUI 2011AA)
    229554006 (SNOMED CT 2011_0131)
    C0521124 (UMLS CUI 2011AA)
    65897001 (SNOMED CT 2011_0131)
    C0011849 (UMLS CUI 2011AA)
    191044006 (SNOMED CT 2011_0131)
    C1319284 (UMLS CUI 2011AA)
    408254005 (SNOMED CT 2011_0131)
    C1409616 (UMLS CUI 2011AA)
    Diagnosis of acute coronary syndrome within 15 to 90 days prior to randomization
    Item
    Diagnosis of acute coronary syndrome within 15 to 90 days prior to randomization
    boolean
    C0011900 (UMLS CUI 2011AA)
    439401001 (SNOMED CT 2011_0131)
    MTHU008876 (LOINC Version 232)
    C0948089 (UMLS CUI 2011AA)
    394659003 (SNOMED CT 2011_0131)
    10051592 (MedDRA 14.1)
    E10066 (CTCAE 1105E)
    C0332152 (UMLS CUI 2011AA)
    288556008 (SNOMED CT 2011_0131)
    C0034656 (UMLS CUI 2011AA)
    Item Group
    Ausschlusskriterien
    CL425201 (UMLS CUI 2011AA)
    Signs of type 1 diabetes mellitus
    Item
    Signs of type 1 diabetes mellitus
    boolean
    C0011854 (UMLS CUI 2011AA)
    Currently receiving a glucagon-like peptide-1 analogue for glycemic control of type 2 diabetes mellitus at Screening
    Item
    Currently receiving a glucagon-like peptide-1 analogue for glycemic control of type 2 diabetes mellitus at Screening
    boolean
    C1514756 (UMLS CUI 2011AA)
    C0061355 (UMLS CUI 2011AA)
    43004008 (SNOMED CT 2011_0131)
    C0243071 (UMLS CUI 2011AA)
    C0005802 (UMLS CUI 2011AA)
    C2587213 (UMLS CUI 2011AA)
    31509003 (SNOMED CT 2011_0131)
    C0011860 (UMLS CUI 2011AA)
    44054006 (SNOMED CT 2011_0131)
    10012613 (MedDRA 14.1)
    E08-E13 (ICD-10-CM Version 2010)
    C1409616 (UMLS CUI 2011AA)
    Received a dipeptidyl peptidase-4 inhibitor for either more than 14 days total or within the 3 months prior to Screening
    Item
    Received a dipeptidyl peptidase-4 inhibitor for either more than 14 days total or within the 3 months prior to Screening
    boolean
    C1514756 (UMLS CUI 2011AA)
    C1827106 (UMLS CUI 2011AA)
    423837000 (SNOMED CT 2011_0131)

    Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

    Campos marcados com * são obrigatórios.

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial